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In Nigeria, Community Pharmacists (CPs) and Patent 
and Proprietary Medicine Vendors (PPMVs) are the first 
point of care for many communities. A CP is a trained 
pharmacist with full license to sell and buy prescription 
and non-prescription drugs and a PPMV is defined as “a 
person without formal training in pharmacy who sells 
orthodox pharmaceutical products on a retail basis for 
profit”[1]. Many women in Nigeria who use a modern 
contraceptive (41%) receive their method from the 
private sector [2]. Although CPs and PPMVs are not 
formally recognized as family planning (FP) service 
providers, they are a popular source for contraception 
among both public and private sources with 22% of 
modern contraceptive users receiving their last method 
from a PPMV and 12 percent receiving their method 
from a private pharmacy [2]. PPMVs are especially 
popular source for FP due to their widespread 
availability, consistent drug stocks, extended hours, 
personable interactions, and no separate fees for 
consultations [3, 4]. CPs and PPMV, however, have not 
received formal training to provide FP services and often 
do not have the necessary knowledge and skills to 
competently provide these services. Previous studies 
have shown that with training, PPMVs can provide 
injectable contraceptives [5]. As the Federal Ministry of 
Health (FMoH) explores expanding its task sharing policy 
to include CPs and PPMVs, evidence is needed on an 
effective regulatory system to support PPMVs and CPs 
to provide high quality FP services. 
THE INTEGRATE PROJECT 
The IntegratE Project is a 4-year initiative (2017-2021) 
funded by the Bill & Melinda Gates Foundation and 
MSD for Mothers1 that seeks to increase access to 
contraceptive methods by involving the private sector 
(CPs and PPMVs) in FP service delivery in Lagos and  
 
1 This programme is co-funded by, developed and is being 
implemented in collaboration with MSD for Mothers, MSD’s $500 
million initiative to help create a world where no woman dies giving 











Kaduna States. IntegratE is implemented by a 
consortium of partners, Marie Stopes International, 
Planned Parenthood Federation of Nigeria, Population 
Council, PharmAccess, and led by the Society for Family 
Health. The project seeks to establish a regulatory 
system with the Pharmacists Council of Nigeria (PCN) to 
ensure that CPs and PPMVs provide quality FP services, 
comply with FP regulations and report service statistics 
to the Health Information Management System (HMIS). 
To achieve this, the IntegratE Project in collaboration 
with PCN and the FMoH, is implementing three main 
activities: (1) a pilot 3-tiered accreditation system for 
PPMVs based on their healthcare qualifications; (2) a 
pilot a hub-and-spoke supervisory model to ensure 
standard drug stocking practices; and (3) building the 
capacity of CPs and PPMVs to provide expanded FP 
services and report service statistics to the HMIS. Under 
the pilot accreditation system, PPMVs are provided with 
a standardized FP training and would provide certain FP 
services based on their tier (Table 1). CPs would function 
outside of the accreditation system but would receive 
the same training and provide the same services as Tier 
2 PPMVs. This brief focuses on knowledge results from 
before and after the FP training that is part of the pilot 
accreditation system. Additional information on 







Table 1: Description of tier accreditation system  
Provider 
type 






• FP counseling and referral 






• FP counseling and referral 
• Injectable administration 
• Implant insertion and removal 
Tier 3 
PPMVs 
PPMVs who are also 
pharmacy 
technicians  
• FP counseling and referral 
• Injectable administration 
• Implant insertion and removal 
CPs Outside of 
accreditation system 
• FP counseling and referral 
• Injectable administration 
• Implant insertion and removal 
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ASSESSING PPMV AND CP 
KNOWLEDGE TO PROVIDE FAMILY 
PLANNING SERVICES 
The IntegratE project is conducting a mixed-methods on 
CPs and PPMVs’ capacity to provide high quality FP 
services. Starting in January 2019, 430 CPs and PPMVs 
from Kaduna and Lagos states trained by the IntegratE 
project were enrolled into the study2. As part of the 
study, enrolled CPs and PPMVs completed a self-
administered questionnaire to assess their knowledge 
related to the provision of FP counseling, and injectable 
and implant contraceptive services immediately before 
and after the training. Additional knowledge 
assessments will be conducted 9-27 months after their 
initial training. Preliminary results from the pre and 
posttest questionnaires are presented in this brief. 
 
RESULTS 
PPMV and CP characteristics 
In both states, over half of PPMVs and CPs were female 
(54% in Kaduna and 58% in Lagos) and 35 years old and 
older (56% in Kaduna and 71% in Lagos; see Table 2). 
The majority were married (79% in Kaduna and 83% in 
Lagos) and approximately three-quarters had attained 
two or more years of post-secondary education (71% in 
Kaduna and 75% in Lagos). In Kaduna, 51% were Tier 2 
PPMVs, 39% were CPs, and 10% were Tier 1 PPMVs. In 
Lagos, two-thirds were CPs (67%), 24% were Tier 1 
PPMVs and 9% were Tier 2 PPMVs.  
 
98% OF RESPONDENTS IN BOTH STATES 
KNEW CONDOMS PREVENT PREGNANCY 
AND STI AT POSTTEST 
 
PPMV and CP general FP counseling 
knowledge 
All enrolled CPs and PPMVs, regardless of tier, were 
trained to provide quality FP counseling. The training 
included: (a) information on the different contraceptive 
methods available in Nigeria; (b) instruction and 
practice sessions on providing client-centered FP 
counseling using the Balance Counseling Strategy 
toolkit; and (c) instruction on how and when to refer 
clients to other sources of care based on the methods 
CPs and PPMVs are authorized to provide and the 
client’s medical eligibility.  Figure 1 shows the proportion 
of respondents who correctly answered key FP 
questions at pretest and posttest. Knowledge was 
 
2 All participants enrolled in the study were given detailed 
information about the study before consenting to participate. 
higher at posttest than at pretest, although knowledge 
remained low for some questions. At posttest, almost all 
(97% in Kaduna and 99% in Lagos) correctly answered 
that condoms are the only method that prevents both 
pregnancy and HIV and a majority correctly answered 
that the client is the most appropriate person to choose 
which FP method to use rather than the provider or her 
husband (87% in Kaduna and 86% in Lagos). At 
posttest, fewer (59% in Kaduna and 66%) in Lagos 
answered that if a client experiences a sudden change 
in health (other than a normal side effect of the method), 
she should be advised to go to the nearest health facility 
and inform them of the method she is using. Less than 
half of respondents in Kaduna (47%) and two-thirds in 
Lagos (66%) correctly identified Copper IUD as a non-
hormonal method at posttest. 
 
At least 79% of CPs and Tier 2 PPMVs 
correctly answered Depo-Provera and 
Sayana Press questions at posttest. 
 
CP and Tier 2 PPMV knowledge of 
injectable contraceptives 
CPs and Tier 2 PPMVs (n=359) were given information 
on injectable contraceptives and practiced 
administering injectables, including Depo-Provera and 








     Male 44.6 41.6 43.3 
     Female 54.1 58.4 56.1 
Age* 
     20-34 39.5 25.4 33.0 
     35+ 56.2 71.2 63.0 
Marital Status* 
     Single 16.3 13.2 14.9 
     Married/ In-union 79.4 83.3 81.2 
     Widowed/divorced 3.4 3.1 3.3 
Highest level of education achieved* 
     Primary 0.9 0.5 0.7 
     Secondary  6.4 16.8 11.2 
     2+ years post-
secondary 
70.8 75.1 72.8 
    Other professional  
    certificate 
15.0 4.1 10.0 
Cadre 
     Tier 1 PPMV  10.3 23.9 16.5 
     Tier 2 PPMV  50.6 9.1 31.6 
     CP 39.1 67.0 51.9 
*Totals do not equal 100 due to missing observations 
  
 













Sayana Press, on dummy models and in a clinical setting 
during the training. Knowledge was generally higher at 
posttest, especially for questions about Sayana Press, 
than at pretest. At posttest, most respondents in 
Kaduna (83%) and Lagos (91%) identified that Depo-
Provera is administered intramuscularly, and that it is 
administered every three months (87% in Kaduna and 
94% in Lagos). Almost all respondents in Lagos (97%) 
and 79% in Kaduna knew that Sayana Press is 
administered subcutaneously, 
and over 80% in each state 
knew that it is administered 
every three months (80% in 
Kaduna and 83% in Lagos). 
Many (87% in Kaduna and 
89% in Lagos) correctly 
identified that Depo-Provera 
and Sayana Press have the 
same active drug and are 
equally effective at preventing 
pregnancy. Few, however, 
correctly answered that the 
content of sharps boxes 
should be disposed of at a 
health facility at posttest 
(Kaduna 24% and 47% in 
Lagos). The most common 
response at posttest was that 
sharps should  be buried in the 
ground (approximately 51% of 
all respondents, data not 
shown). 
 
Tier 2 PPMV and CP knowledge of 
contraceptive implants  
CPs and Tier 2 PPMVs were given information on, and 
practiced inserting, contraceptive implants during their 
training. They were also asked questions about 
knowledge before and after the training. Across both 
states and for all key indicators shown, implant 












































Client should go to
health facility/inform
them of the method
she uses if health
changes
Pre-test Posttest
Figure 1: CP and PPMV knowledge of FP counseling on the self-administered pre-
test and posttest (n=430)




















































































(Figure 3). For example, over three-quarters of CPs and 
Tier 2 PPMVs in each state knew that the Nexplanon 
implant is effective for three years at posttest (76% in 
Kaduna and 78% in Lagos). Most (88% in Kaduna and 
95% in Lagos 95%) knew that the implant is inserted 
under the skin of the arm. Fewer correctly identified the 
angle at which Nexplanon must be inserted: 37% in 
Kaduna and 49% in Lagos. At posttest, just over half of 
respondents in Kaduna (53%) and two-thirds in Lagos 
(67%) knew that implants inserted into the fat under the 
skin may be more difficult to remove.  
 
The proportion of CPs and Tier 2 PPMVs 
who correctly answered these 4 implant 




Preliminary results from the pretest and posttest are 
promising and suggest that PPMVs and CPs can be 
trained on general FP counseling using a standardized 
training curriculum. Additional attention is needed to 
improve knowledge of non-hormonal methods, such as 
the copper IUD, and how to counsel clients if they 
experience a sudden change in their health. Results also 
suggest that trainings should focus additional attention 
on how and where to dispose of sharps, and of the angle 
at which Nexplanon must be inserted. The role of job 
aids to reinforce knowledge will also be explored as 
demonstrated by a previous study [6]. Overall, results 
are promising for expanding the role of CPs and PPMVs 
service delivery in Nigeria. 
 







































effective for 3 years
Implant is inserted under the
skin of the arm
Nexplanon must be inserted
at a 30° angle
Implants inserted into the fat
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